REVIVA PHARMACEUTICALS HOLDINGS, INC.

Reviva Pharmaceuticals Holdings, Inc. (Nasdaq: RVPH) is a clinical-stage biopharmaceutical company focused on central nervous system disorders that reached public markets through a SPAC merger with Tenx Keane Acquisition Corp., a blank-check vehicle sponsored by Tenx Keane Capital Management that completed its initial public offering in 2021. The company operates in the healthcare and life sciences sector, advancing a pipeline of CNS drug candidates. An 8-K filing dated December 23, 2025 reflects RVPH's ongoing post-merger public reporting obligations. Sign up for full data on SpacDesk to access complete filing histories, deal timelines, and sponsor profiles for RVPH and hundreds of other SPAC transactions.